恒指跌幅扩至逾千点考验29,000 美团与药明生物急挫8%-9%
全球多国债息明显上升,其中美国十年期债息昨晚曾触及1.6%为去年中以来首见,引发市场忧虑情绪。中澳韩台日及印度股市急吐2.1%-3.5%,其中日经急泻1,202点或4%低收28,966。
1月贸易数据远胜预期的港股午後在金融股加入沽压行列後,跌幅持续扩大,最低见29,004,恒指急泻1,052点或3.5%报29,021,成交额2,616亿元。
美团(03690.HK)及药明生物(02269.HK)跌幅扩至8%及9%,分别报340.8元及95元。港交所(00388.HK)挫5.2%曾低见468元。
银娱(00027.HK)、小米(01810.HK)、百威亚太(01876.HK)、舜宇(02382.HK)及中海油(00883.HK)也跌逾5%-6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.